NCT01225510View on ClinicalTrials.gov

A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Glioblastoma
Interventions
BIOLOGICAL

PF-04856884

PF-04856884 at a dose of 15 mg/kg/week

BIOLOGICAL

PF-04856884

PF-04856884 at a dose of 15 mg/kg/week

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY